Organisation paid for research Program year 2025 Source: CMS Open Payments

A&B Clinical Research Inc

Neither a doctor nor a teaching hospital

Research payments

$22,325

8 payments

Through program year 2025, A&B Clinical Research Inc is reported as receiving $22,325 in research payments, across 8 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$2,411	1
2024	Research	$9,417	4
2023	Research	$2,498	1
2022	Research	$3,000	1
2021	Research	$5,000	1

Breakdown

Who paid Research payments · program years 2021–2025

AbbVie, Inc. $22,325 8 payments

Studies the money was for Research payments · program years 2021–2025

Study of Oral Elagolix Tablets in Combination With Combined Oral Contraceptive Capsules Tablets to Assess Dysmenorrhea Response in Adult Female Participants With Endometriosis and Associated Moderate to Severe Pain $8,560 3 payments
A Phase 3b Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Combined Oral Contraceptives in Premenopausal Women with Documented Endometriosis and Associated Moderate to Severe Pain $5,000 1 payment
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsulesx2FTablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain $3,000 1 payment
Study of Oral Elagolix Tablets in Combination With Combined Oral Contraceptive Capsules Tablets to Assess Dysmenorrhea Response in Adult Female Participants With Endometriosis and Associated Moderate to Severe Pain $2,678 1 payment
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules;Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain $2,498 1 payment
Study of Oral Elagolix Tablets in Combination With Combined Oral Contraceptive Capsules Tablets to Assess Dysmenorrhea Response in Adult Female Participants With Endometriosis and Associated Moderate to Severe Pain $589 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.